Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02739789 · ClinicalTrials.gov registry record · NA

Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study

A NA study of Healthy, sponsored by Stony Brook University.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT02739789: Completed NA study of Healthy, sponsored by Stony Brook University.

NCT02739789 is a NA study of Healthy that has completed, run by Stony Brook University. The registered enrollment target is 19 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02739789, a NA study of Healthy, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

This research study identifies neural pathways regulating negative moods during rejection by combining transcranial direct current stimulation (tDCS) and fMRI in a sample of healthy controls.

Conditions Studied

Healthy

Interventions

  • DEVICE Sham tDCS
  • DEVICE tDCS

Study Locations (1)

New York

  • Stony Brook University - Stony Brook

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-02-14
Est. Completion 2018-10-16
Phase NA

Sponsor

Stony Brook University

127 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02739789

The ClinicalTrials.gov registry entry for NCT02739789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.

NCT02739789 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02739789 about?

NCT02739789 is a clinical study titled "Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study". This research study identifies neural pathways regulating negative moods during rejection by combining transcranial direct current stimulation (tDCS) and fMRI in a sample of healthy controls.

What is the current status of trial NCT02739789?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-02-14. Estimated completion is 2018-10-16.

What conditions does trial NCT02739789 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02739789?

The interventions under investigation include: Sham tDCS (DEVICE), tDCS (DEVICE).

Who is sponsoring clinical trial NCT02739789?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02739789 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.